Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

September 30, 2006

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Modafinil

Trial Locations (23)

23510

Monarch Research Associates, Norfolk

27717

Triangle Neuropsychiatry, Durham

28226

Piedmont Neuropsychiatry, Charlotte

30342

Child Neurology Associates, Atlanta

32607

Sarkis Family Psychiatry, Gainesville

33013

Amedica Research Institute, Inc., Hialeah

33173

Miami Research Associates, Miami

40004

Kentucky Pediatric/Adult Research, Bardstown

40509

Michael J. Rieser, MD, PSC, Lexington

42001

Four Rivers Clinical Research, Inc., Paducah

48085

Clinical Neurophysiology Services, Troy

68198

University of Nebraska, Omaha

72205

Clinical Study Centers, LLC, Little Rock

73118

Pahl Pharmaceutical Research, Inc., Oklahoma City

80304

Alpine Clinical Research, Boulder

91978

Encompass Clinical Research, Spring Valley

92612

UCI Child Development Center, Irvine

94143

University of California at San Francisco, San Francisco

97301

OCCI, Inc., Salem

98033

Eastside Therapeutic Resource, Kirkland

98133

Pacific Institute Mental Health, Seattle

08021

CNS Research Institute, Clementon

05401

The Clinical Study Center, Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cephalon

INDUSTRY

NCT00343811 - Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment | Biotech Hunter | Biotech Hunter